Integral Health Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Integral Health Asset Management’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14M	Hold	200,000	–	–	0.67%	35
2025 Q4	$16.4M	Sell	200,000 -50,000	-20%	-$3.73M	0.81%	45
2025 Q3	$14.9M	Buy	250,000 +50,000	+25%	+$2.46M	1.01%	31
2025 Q2	$8.1M	Hold	200,000	–	–	0.74%	39
2025 Q1	$10.3M	Sell	200,000 -150,000	-43%	-$7.41M	1.09%	28
2024 Q4	$19.4M	Sell	350,000 -25,000	-7%	-$1.14M	1.65%	21
2024 Q3	$12.3M	Sell	375,000 -215,000	-36%	-$6.04M	1.39%	21
2024 Q2	$16M	Hold	590,000	–	–	1.52%	19
2024 Q1	$21.4M	Buy	590,000 +490,000	+490%	+$14.4M	1.99%	14
2023 Q4	$2.02M	Buy	+100,000	New	+$1.67M	0.28%	67

Other funds holding TARS

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Integral Health Asset Management's TARS Position: Q1 2026 in Review

Integral Health Asset Management held its Tarsus Pharmaceuticals (TARS) position steady in Q1 2026 at 200,000 shares worth $14M. The position accounts for 0.67% of the portfolio, ranked #35.

Integral Health Asset Management first reported a position in TARS in Q4 2023 and has held it in 10 quarters since. The position peaked at $21.4M in Q1 2024. 253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

Integral Health Asset Management held 200,000 shares of Tarsus Pharmaceuticals worth $14M as of Q1 2026.
Integral Health Asset Management left its Tarsus Pharmaceuticals share count unchanged in Q1 2026.
Tarsus Pharmaceuticals made up 0.67% of Integral Health Asset Management's portfolio in Q1 2026, its #35 holding.
Integral Health Asset Management first reported a position in Tarsus Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
Integral Health Asset Management's Tarsus Pharmaceuticals position peaked at $21.4M in Q1 2024.
253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.